1
|
Canine Distemper Virus in Endangered Species: Species Jump, Clinical Variations, and Vaccination. Pathogens 2022; 12:pathogens12010057. [PMID: 36678405 PMCID: PMC9862170 DOI: 10.3390/pathogens12010057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2022] [Revised: 12/26/2022] [Accepted: 12/27/2022] [Indexed: 12/31/2022] Open
Abstract
Canine morbillivirus (Canine distemper virus, CDV) is the cause of distemper in a large number of different species, some of which are endangered. The clinical outcome associated with infection is variable and based on many factors, including the host species, the immune response of the individual animal to the infection, and variation in virus tropism and virulence. Unfortunately, the viral characteristics associated with virulence versus attenuation are not fully characterized, nor are the specific mutations that allow this virus to easily move and adapt from one species to another. Due to its wide host range, this virus is difficult to manage in ecosystems that are home to endangered species. Vaccination of the domestic dog, historically considered the reservoir species for this virus, at dog-wildlife interfaces has failed to control virus spread. CDV appears to be maintained by a metareservoir rather than a single species, requiring the need to vaccinate the wildlife species at risk. This is controversial, and there is a lack of a safe, effective vaccine for nondomestic species. This review focuses on topics that are paramount to protecting endangered species from a stochastic event, such as a CDV outbreak, that could lead to extinction.
Collapse
|
2
|
Du X, Goffin E, Gillard L, Machiels B, Gillet L. A Single Oral Immunization with Replication-Competent Adenovirus-Vectored Vaccine Induces a Neutralizing Antibody Response in Mice against Canine Distemper Virus. Viruses 2022; 14:v14091847. [PMID: 36146652 PMCID: PMC9501072 DOI: 10.3390/v14091847] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2022] [Revised: 08/17/2022] [Accepted: 08/19/2022] [Indexed: 12/02/2022] Open
Abstract
Canine Distemper Virus (CDV) is a fatal and highly contagious pathogen of multiple carnivores. While injectable vaccines are very effective in protecting domestic animals, their use in the wild is unrealistic. Alternative vaccines are therefore needed. Adenovirus (AdV) vectors are popular vaccine vectors due to their capacity to elicit potent humoral and cellular immune responses against the antigens they carry. In parallel, vaccines based on live human AdV-4 and -7 have been used in U.S. army for several decades as replicative oral vaccines against respiratory infection with the same viruses. Based on these observations, the use of oral administration of replication competent AdV-vectored vaccines has emerged as a promising tool especially for wildlife vaccination. Developing this type of vaccine is not easy, however, given the high host specificity of AdVs and their very low replication in non-target species. To overcome this problem, the feasibility of this approach was tested using mouse adenovirus 1 (MAV-1) in mice as vaccine vectors. First, different vaccine vectors expressing the entire or part H or F proteins of CDV were constructed. These different strains were then used as oral vaccines in BALB/c mice and the immune response to CDV was evaluated. Only the strain expressing the full length CDV H protein generated a detectable and neutralizing immune response to CDV. Secondly, using this strain, we were able to show that although this type of vaccine is sensitive to pre-existing immunity to the vector, a second oral administration of the same vaccine is able to boost the immune response against CDV. Overall, this study demonstrates the feasibility of using replicating AdVs as oral vaccine vectors to immunize against CDV in wildlife carnivores.
Collapse
|
3
|
CANINE DISTEMPER AND PARVOVIRUS VACCINATION WITH RECOMBITEK C3 IN AFRICAN WILD DOGS ( LYCAON PICTUS). J Zoo Wildl Med 2022; 52:1229-1233. [PMID: 34998293 DOI: 10.1638/2021-0004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/04/2021] [Indexed: 11/21/2022] Open
Abstract
Infectious disease threats are increasingly recognized as a major contributor to mortality in wild populations of African wild dog (Lycaon pictus, AWD). Canine distemper virus (CDV) infection has been implicated as a cause of pack mortality in both captive and wild AWD populations. Ten animals were vaccinated with RecombitekTM C3, a vaccine containing a recombinant CDV, and modified live canine parvovirus (CPV) and adenovirus-2 components, at 8, 12, and 16 wk of age. Half of the pups received the vaccine IM and the other half SC. All ten pups had a positive serological response to CDV after the second vaccination, which decreased or stagnated after the third vaccination. Half of the pups had CDV titers ≥32 at 20 wk of age. Titers to CPV were high in all pups prior to vaccination and dropped precipitously over the course of the vaccine series. At the last sampling period, only 50% of the pups had measurable CPV titers. An initially higher titer was seen for CDV in the IM administration group; however, this was not significant at later time points. Vaccination with Recombitek C3 appears to be safe and effected a sustained serological response to CDV in AWD.
Collapse
|
4
|
MODIFIED LIVE DISTEMPER VACCINES CARRY LOW MORTALITY RISK FOR CAPTIVE AFRICAN WILD DOGS, LYCAON PICTUS. J Zoo Wildl Med 2021; 52:176-184. [PMID: 33827174 DOI: 10.1638/2020-0045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/10/2020] [Indexed: 11/21/2022] Open
Abstract
Recently, canine distemper virus (CDV) has been linked to population declines in the endangered African wild dog (Lycaon pictus). As CDV appears able to persist in wildlife, threats to free-ranging wild dogs cannot be eliminated by vaccinating domestic dogs. Conservation managers may therefore consider CDV vaccination of wild dogs in highly threatened populations. For use in field conservation, the ideal CDV vaccine would be safe, immunogenic, and readily available in Africa. The CDV vaccine type most commonly used for domestic dogs (modified live vaccine) is available in Africa, and apparently immunogenic in wild dogs, but has been linked to fatal vaccine-induced distemper in captive wild dogs. However, alternatives are either ineffective (inactivated vaccine) or difficult to obtain in Africa (recombinant vaccine). Data from a questionnaire survey of zoo vaccination practices were therefore combined with studbook tracing to assess the safety of modified live CDV vaccine in captive African wild dogs. Among 135 wild dog pups given modified live CDV vaccine for the first time, there was a single, unconfirmed, case of potential vaccine-induced distemper. Pups given modified live vaccine survived better than those given inactivated vaccine or no vaccine. Although studbook tracing revealed higher overall pup survival at zoos which responded to the questionnaire than at zoos which did not, tracing of all pups born during a 20-yr period that lived long enough to be vaccinated (n = 698 pups in 155 litters) revealed no mortality events consistent with vaccine-induced distemper. Modified live CDV vaccine thus appears to carry low mortality risks for African wild dog pups in captivity, and may warrant trials in free-ranging populations.
Collapse
|
5
|
Vergara-Wilson V, Hidalgo-Hermoso E, Sanchez CR, Abarca MJ, Navarro C, Celis-Diez S, Soto-Guerrero P, Diaz-Ayala N, Zordan M, Cifuentes-Ramos F, Cabello-Stom J. Canine Distemper Outbreak by Natural Infection in a Group of Vaccinated Maned Wolves in Captivity. Pathogens 2021; 10:pathogens10010051. [PMID: 33429927 PMCID: PMC7827803 DOI: 10.3390/pathogens10010051] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2020] [Revised: 01/01/2021] [Accepted: 01/05/2021] [Indexed: 11/24/2022] Open
Abstract
Canine distemper virus (CDV) is one of the most significant infectious disease threats to the health and conservation of free-ranging and captive wild carnivores. CDV vaccination using recombinant canarypox-based vaccines has been recommended for maned wolf (Chrysocyon brachyurus) after the failure of modified live vaccines that induced disease in vaccinated animals. Here, we report a CDV outbreak in a captive population of maned wolves that were previously vaccinated. Five juveniles and one adult from a group of seven maned wolves housed in an outdoor exhibit died in April–May 2013 in a zoo in the Metropolitan Region, Chile. Clinical signs ranged from lethargy to digestive and respiratory signs. Diagnosis of CDV was confirmed by histopathology, antibody assays, and viral molecular detection and characterization. The phylogenetic analyses of the nucleotide sequence of the H gene of the CDV genome identified in the two positive samples suggest a close relation with the lineage Europe 1, commonly found in South America and Chile. CDV infections in maned wolves have not been previously characterized. To the authors’ best knowledge, this is the first report of the clinical presentation of CDV in a canine species previously immunized with a recombinant vaccine.
Collapse
Affiliation(s)
- Vicente Vergara-Wilson
- Conservation and Research Department, Parque Zoologico Buin Zoo, Panamericana Sur Km 32, Buin 9500000, Chile; (V.V.-W.); (N.D.-A.); (M.Z.)
| | - Ezequiel Hidalgo-Hermoso
- Conservation and Research Department, Parque Zoologico Buin Zoo, Panamericana Sur Km 32, Buin 9500000, Chile; (V.V.-W.); (N.D.-A.); (M.Z.)
- Departamento de Veterinaria, Parque Zoologico Buin Zoo, Panamericana Sur Km 32, Buin 9500000, Chile; (S.C.-D.); (P.S.-G.)
- Correspondence:
| | - Carlos R. Sanchez
- Living Collection Unit, Veterinary Medical Center, Oregon Zoo, Portland, OR 97221, USA;
| | - María J. Abarca
- Faculty of Animal and Veterinary Sciences, University of Chile, Av. Santa Rosa, Santiago 11735, Chile; (M.J.A.); (C.N.); (F.C.-R.)
| | - Carlos Navarro
- Faculty of Animal and Veterinary Sciences, University of Chile, Av. Santa Rosa, Santiago 11735, Chile; (M.J.A.); (C.N.); (F.C.-R.)
| | - Sebastian Celis-Diez
- Departamento de Veterinaria, Parque Zoologico Buin Zoo, Panamericana Sur Km 32, Buin 9500000, Chile; (S.C.-D.); (P.S.-G.)
| | - Pilar Soto-Guerrero
- Departamento de Veterinaria, Parque Zoologico Buin Zoo, Panamericana Sur Km 32, Buin 9500000, Chile; (S.C.-D.); (P.S.-G.)
| | - Nataly Diaz-Ayala
- Conservation and Research Department, Parque Zoologico Buin Zoo, Panamericana Sur Km 32, Buin 9500000, Chile; (V.V.-W.); (N.D.-A.); (M.Z.)
| | - Martin Zordan
- Conservation and Research Department, Parque Zoologico Buin Zoo, Panamericana Sur Km 32, Buin 9500000, Chile; (V.V.-W.); (N.D.-A.); (M.Z.)
- World Association of Zoos and Aquariums (WAZA), Carrer de Roger de Llúria, 2, 2-208010 Barcelona, Spain
| | - Federico Cifuentes-Ramos
- Faculty of Animal and Veterinary Sciences, University of Chile, Av. Santa Rosa, Santiago 11735, Chile; (M.J.A.); (C.N.); (F.C.-R.)
| | - Javier Cabello-Stom
- Patagonia Campus, School of Veterinary Medicine, Universidad San Sebastian, Puerto Montt 5480000, Chile;
| |
Collapse
|
6
|
REVIEW OF CANINE DISTEMPER VACCINATION USE AND SAFETY IN NORTH AMERICAN CAPTIVE LARGE FELIDS (PANTHERA SPP.) FROM 2000 TO 2017. J Zoo Wildl Med 2020; 50:778-789. [PMID: 31926507 DOI: 10.1638/2018-0163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/10/2019] [Indexed: 11/21/2022] Open
Abstract
Data on canine distemper virus (CDV) vaccination were collected on 812 large felids (351 tigers, Panthera tigris; 220 lions, Panthera leo; 143 snow leopards, Panthera uncia; 50 leopards, Panthera pardus; and 48 jaguars, Panthera onca) from 48 institutions to assess vaccine use and safety. The documented individual vaccination events with multiple products numbered 2,846. Canarypox-vectored CDV vaccines were the most commonly used vaccines (96.3% of all vaccinations) and the Purevax® Ferret Distemper (PFD) vaccine was the most commonly used canarypox-vectored vaccine (91.0% of all vaccinations). Modified live virus (MLV) CDV vaccines were used for 3.7% of all vaccinations, and only in tigers, lions, and snow leopards. Adverse effects were reported after 0.5% (13 of 2,740) of the canarypox-vectored vaccinations and after 2.9% (3 of 104) of the MLV CDV vaccinations. This low complication rate suggests large felids may not be as sensitive to adverse effects of MLV CDV vaccines as other exotic carnivores. Serological data were available from 159 individuals (69 tigers, 31 lions, 31 snow leopards, 22 jaguars, and 6 Amur leopards, Panthera pardus orientalis) vaccinated with the PFD vaccine, and 66.0% of vaccinates seroconverted (defined as acquiring a titer ≥1: 24) at some point postvaccination: 24.3% after one vaccination, 55.8% after two vaccinations, 54.3% after three vaccinations, and 79.2% after four or more vaccinations. Among animals exhibiting seroconversion after the initial PFD vaccinations, 88.9% still had titers ≥12 mo and ≥24 mo after the last vaccination, and 87.5% had titers ≥1: 24 at ≥36 mo after the last vaccination. The study was unable to assess fully the safety of vaccination with either canarypox-vectored or MLV CDV vaccines during gestation because of the small number of animals vaccinated while pregnant (n = 6, all vaccinated with PFD).
Collapse
|
7
|
TIGER ( PANTHERA TIGRIS) AND DOMESTIC CAT ( FELIS CATUS) IMMUNE RESPONSES TO CANARYPOX-VECTORED CANINE DISTEMPER VACCINATION. J Zoo Wildl Med 2020; 50:798-802. [PMID: 31926509 DOI: 10.1638/2019-0049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/17/2019] [Indexed: 11/21/2022] Open
Abstract
Two methods for delivering a canarypox-vectored canine distemper vaccine to tigers (Panthera tigris) and domestic cats (Felis catus) were investigated. Eight tigers were divided randomly into two vaccination groups: subcutaneous injection or topical tonsillar application. Each tiger received 2 ml of canine distemper virus (CDV) vaccine (Merial Ferret Distemper Vaccine). Blood was collected from tigers on days 0, 21, 35 or 37, and 112 post-initial vaccination (PIV). Domestic cats were divided randomly into four treatment groups: saline injection (negative controls), low- and high-dose oral, and subcutaneous vaccinates. Blood was collected from domestic cats on days 0, 7, 21, and 28 and 165 or 208 PIV. Sera were tested for CDV antibodies by virus neutralization. All individuals were seronegative at the beginning of the study. One tiger vaccinated subcutaneously developed a titer of 32 by day 35, which reduced to 16 by day 112. Another tiger vaccinated by tonsillar application developed a titer of 8 on day 112. All other tigers remained seronegative. Cats that received saline injection or oral vaccination remained seronegative at each sampling time. Domestic cats vaccinated subcutaneously developed titers ranging from 4 to >128 by day 28, and those re-bled at day 166 had titers of 16 or 64. The disparity in response between domestic cats and tigers may be due to species differences or it may represent a dose-dependent effect. Subcutaneous vaccination with canarypox-vectored Purevax Ferret Distemper® is safe and elicits persistent antibody titers in domestic cats vaccinated parenterally.
Collapse
|
8
|
Davidson-Phillips S, Davidson-Phillips P, Canning G, Schroder B, Swart J, Burger A. Canine Distemper Virus Management in Lions (Panthera leo) on Welgevonden Game Reserve. AFRICAN JOURNAL OF WILDLIFE RESEARCH 2019. [DOI: 10.3957/056.049.0155] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]
Affiliation(s)
| | | | - Gregory Canning
- Welgevonden Game Reserve, P.O Box 433, Vaalwater, 0530 South Africa
| | - Bradley Schroder
- Welgevonden Game Reserve, P.O Box 433, Vaalwater, 0530 South Africa
| | - Jonathan Swart
- Welgevonden Game Reserve, P.O Box 433, Vaalwater, 0530 South Africa
| | - André Burger
- Welgevonden Game Reserve, P.O Box 433, Vaalwater, 0530 South Africa
| |
Collapse
|
9
|
Anderson N, Smith I. Assessing the immunogenicity of an inactivated monovalent vaccine in the endangered African wild dog ( Lycaon pictus). Vaccine X 2019; 1:100006. [PMID: 31384728 PMCID: PMC6668226 DOI: 10.1016/j.jvacx.2019.100006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2018] [Revised: 12/22/2018] [Accepted: 12/31/2018] [Indexed: 11/17/2022] Open
Abstract
Captive held African wild dogs (Lycaon pictus) were vaccinated with a commercially available inactivated canine parvovirus (CPV) vaccine licensed for use in domestic dogs. Serological responses were recorded by testing for viral antibodies with the haemagglutination inhibition test (HAI) following a vaccination schedule involving two initial inoculations a month apart and an annual booster. Vaccines were delivered by hand injection or remotely (i.e. by dart). All naïve dogs vaccinated with Parvac® did seroconvert as determined by canine antibody titres ≥ 1:80 in one or more samples collected after inoculation. Duration of immunity (DOI) within the first year persisted for approximately 98 days only. To enable greater immunological protection revaccination should occur more frequently than once in a calendar year. No significant differences in the seroprotection rate were observed when comparing route of administration.
Collapse
Affiliation(s)
- Nicole Anderson
- Zoos South Australia, Frome Road, Adelaide, SA 5001, Australia
- College of Humanities, Arts & Social Science, Flinders University, GPO Box 2100, Bedford Park, Australia
| | - Ian Smith
- Zoos South Australia, Frome Road, Adelaide, SA 5001, Australia
| |
Collapse
|
10
|
Overview of African Wild Dog Medicine. FOWLER'S ZOO AND WILD ANIMAL MEDICINE CURRENT THERAPY, VOLUME 9 2019:539-547. [PMCID: PMC7151821 DOI: 10.1016/b978-0-323-55228-8.00077-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/12/2023]
|
11
|
Day MJ, Horzinek MC, Schultz RD, Squires RA. WSAVA Guidelines for the vaccination of dogs and cats. J Small Anim Pract 2016; 57:E1-E45. [PMID: 26780857 PMCID: PMC7166872 DOI: 10.1111/jsap.2_12431] [Citation(s) in RCA: 172] [Impact Index Per Article: 21.5] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2015] [Revised: 10/05/2015] [Accepted: 10/30/2015] [Indexed: 01/12/2023]
Affiliation(s)
- M J Day
- University of Bristol, United Kingdom
| | - M C Horzinek
- (Formerly) University of Utrecht, the Netherlands
| | - R D Schultz
- University of Wisconsin-Madison, Wisconsin, USA
| | - R A Squires
- James Cook University, Queensland, Australia
| | | |
Collapse
|
12
|
CANINE DISTEMPER VIRUS ANTIBODY TITERS IN DOMESTIC CATS AFTER DELIVERY OF A LIVE ATTENUATED VIRUS VACCINE. J Zoo Wildl Med 2016; 47:551-7. [DOI: 10.1638/2015-0182.1] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
|